- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1783EUR$2,000USD£1,542GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1337EUR$1,500USD£1,156GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1783EUR$2,000USD£1,542GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,156GBP
- Report
- June 2024
- 200 Pages
Global
From €7087EUR$7,950USD£6,128GBP
- Report
- June 2025
- 138 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- May 2024
- 134 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- April 2023
- 110 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- December 2023
- 221 Pages
Global
From €3208EUR$3,599USD£2,774GBP
- Report
- July 2024
- 162 Pages
Africa
From €2228EUR$2,500USD£1,927GBP
- Report
- July 2024
- 164 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- May 2025
- 134 Pages
Global
From €16041EUR$17,995USD£13,870GBP
- Report
- December 2024
- 59 Pages
Global
From €3561EUR$3,995USD£3,079GBP
- Report
- March 2024
- 95 Pages
Europe
From €1337EUR$1,500USD£1,156GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1337EUR$1,500USD£1,156GBP
- Report
- March 2024
- 91 Pages
North America
From €1337EUR$1,500USD£1,156GBP
- Report
- March 2024
- 97 Pages
Middle East, Africa
From €1337EUR$1,500USD£1,156GBP
- Report
- March 2024
- 143 Pages
Global
From €3209EUR$3,600USD£2,775GBP
- Report
- February 2024
- 73 Pages
Global
From €3500EUR$4,206USD£3,132GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more